Daniel Kolder, MD
Surgery · Camarillo, CANPI 1942393053
Payments from drug & device makers
Across 95 payments — averaging $59.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Tepha Inc$255
- Merz North America, Inc.$208
- Sanofi$164
- Regeneron Healthcare Solutions, Inc.$142
- Incyte Corporation$118
- plus $343 from 9 others
What the payments were for
- Speaking & faculty fees$84915%
- Food & beverage$2,09937%
- Education$250%
- Gifts$2,70048%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $4,445 |
| Tepha Inc | 5 | $255 |
| Merz North America, Inc. | 3 | $208 |
| Sanofi | 4 | $164 |
| Regeneron Healthcare Solutions, Inc. | 5 | $142 |
| Incyte Corporation | 5 | $118 |
| Johnson & Johnson | 3 | $69 |
| Lilly USA, LLC | 3 | $57 |
| Organon | 2 | $49 |
| Sun Pharmaceutical Industries Inc. | 2 | $49 |
| Smith+Nephew | 1 | $39 |
| Sientra, Inc. | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $20 |
| LEO Pharma Inc. | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$2,846
- GalaFLEX$134
- NATRELLE SALINE-FILLED BREAST IMPLANTS$114
How this compares
$5,674 in reported general payments places this provider in the 65th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 27 | $4,484 |
| Fluorouracil | 22 | $1,439 |
| Clobetasol Propionate | 21 | $1,068 |
| Ketoconazole | 60 | $678 |
| Triamcinolone Acetonide | 58 | $375 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 38 | $324 |
| Doxycycline Hyclate | 19 | $260 |
| Acyclovir | 64 | $211 |
| Ciclopirox | 19 | $203 |
| Ondansetron Hcl | 33 | $194 |
| Minoxidil | 15 | $89 |
| Hydroxyzine Hcl | 15 | $73 |
| Hydrocortisone | 14 | $63 |
Paid to pharmacies, not to this prescriber.
Other surgery in Camarillo
- Timothy ChuterSan Francisco$8.9M
- Peter StockSan Francisco$6.5M
- Santiago HorganSan Diego$2.8M
- Kenneth DeckLaguna Hills$2.4M
- Daniel RiskinSan Jose$2.2M
- Michael DemeureNewport Beach$1.7M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
- Siew-Ming LeeFresno$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.